UPDATE 1-Edwards Lifesciences raises outlook on strong valve sales

July 28 (Reuters) - Edwards Lifesciences Corp on Tuesday raised its full-year profit forecast citing strong demand for the medical device maker's replacement heart valves that are implanted in a minimally invasive procedure.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.